[{"NetIncomeLoss_3_Q3_USD":-1712000.0,"PurchaseObligation_0_Q3_USD":196100000.0,"Depreciation_3_Q3_USD":21500000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-11583000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-17451000.0,"InventoryFinishedGoods_0_Q3_USD":30268000.0,"InterestPaidNet_3_Q3_USD":10657000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":11017000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":248422000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q3_USD":35000.0,"PaymentsToAcquireInvestments_3_Q3_USD":0.0,"LiabilitiesNoncurrent_0_Q3_USD":411632000.0,"EquityMethodInvestmentUnderlyingEquityInNetAssets_0_Q3_USD":2374000.0,"AccountsAndOtherReceivablesNetCurrent_0_Q3_USD":714000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":640699982.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":640619485.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":1100000000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":219194000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":300000.0,"LineOfCredit_0_Q3_USD":10993000.0,"OperatingLeaseLiability_0_Q3_USD":37305000.0,"PaidInKindInterest_3_Q3_USD":7639000.0,"LongTermLineOfCredit_0_Q3_USD":0.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":11017000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":3855000.0,"GainLossOnDerivativeInstrumentsNetPretax_3_Q3_USD":112000.0,"IncomeTaxesPaidNet_3_Q3_USD":148000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":208000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":6777000.0,"TreasuryStockValue_0_Q3_USD":1791000.0,"InventoryValuationReserves_0_Q3_USD":3681000.0,"FinanceLeaseInterestExpense_3_Q3_USD":2300000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":669000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":669000.0,"FinanceLeaseInterestPaymentOnLiability_3_Q3_USD":149000.0,"AccountsReceivableGrossCurrent_0_Q3_USD":243540000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1218000.0,"OtherInventorySupplies_0_Q3_USD":72518000.0,"ContractWithCustomerLiability_0_Q3_USD":17050000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":2538000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":99897000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":253749000.0,"OtherLiabilitiesAndDeferredRevenueNoncurrent_0_Q3_USD":26889000.0,"AssetsCurrent_0_Q3_USD":428109000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":5996000.0,"TreasuryStockShares_0_Q3_shares":549907.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q3_USD":-496000.0,"FinanceLeaseLiability_0_Q3_USD":4881000.0,"GainLossOnInvestments_3_Q3_USD":-433000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-3178000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":4021000.0,"RepaymentsOfSeniorDebt_3_Q3_USD":0.0,"AccountsReceivableNetCurrent_0_Q3_USD":241544000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":4749000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":10637000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":88988000.0,"AssetsFairValueDisclosure_0_Q3_USD":12929000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":2009000.0,"NumberOfReportableSegments_3_Q3_segment":2.0,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q3_USD":-1365000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":391000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":342414000.0,"InventoryRawMaterials_0_Q3_USD":6343000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":45836000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":18493000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":57862000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":3154000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-4717000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":5340000.0,"InventoryWriteDown_3_Q3_USD":3400000.0,"GainLossOnInvestments_1_Q3_USD":-110000.0,"CommonStockValue_0_Q3_USD":6706000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":742932000.0,"Liabilities_0_Q3_USD":747521000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":15110000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":28225000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":36294000.0,"OtherAssetsNoncurrent_0_Q3_USD":5857000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":13879000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":43753000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3261000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":37671000.0,"ProceedsFromIssuanceOrSaleOfEquity_3_Q3_USD":669000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2242000.0,"OtherAssetsCurrent_0_Q3_USD":7542000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q3_USD":5089000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":1083000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":1334000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-43184000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":21036000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":65295000.0,"ProceedsFromLinesOfCredit_3_Q3_USD":699079000.0,"Supplies_0_Q3_USD":9435000.0,"IncreaseDecreaseInInventories_3_Q3_USD":60565000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":32018000.0,"EquitySecuritiesFvNi_0_Q3_USD":12720000.0,"CommonStockSharesIssued_0_Q3_shares":670550201.0,"AccountsPayableCurrent_0_Q3_USD":65685000.0,"LiabilitiesCurrent_0_Q3_USD":335889000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":7737000.0,"PaymentsToAcquireProductiveAssets_3_Q3_USD":26885000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":2374000.0,"InventoryWorkInProcess_0_Q3_USD":6425000.0,"GainLossOnDispositionOfAssets1_3_Q3_USD":10172000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":5218000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":8301000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":4619000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":6777000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":192000.0,"Goodwill_0_Q3_USD":675795000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.043,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":8301000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":4619000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-110000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-433000.0,"AmortizationOfFinancingCosts_3_Q3_USD":626000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2740000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":18376000.0,"NonoperatingIncomeExpense_3_Q3_USD":-5616000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":36294000.0,"NetIncomeLoss_1_Q3_USD":23717000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":134102000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":8643000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q3_USD":100974000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":119182000.0,"PrepaidInsurance_0_Q3_USD":6635000.0,"LinesOfCreditCurrent_0_Q3_USD":12702000.0,"OperatingLeasePayments_3_Q3_USD":13596000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":486418000.0,"NonoperatingIncomeExpense_1_Q3_USD":-1290000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":1623770000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":277000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":270000.0,"EquitySecuritiesFvNiRealizedGainLoss_3_Q3_USD":8959000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.064,"DerivativeFairValueOfDerivativeAsset_0_Q3_USD":38000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":620000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":73246000.0,"LongTermDebtNoncurrent_0_Q3_USD":4010000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":38398000.0,"AdditionalPaidInCapital_0_Q3_USD":3150437000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":731000.0,"ContractWithCustomerLiabilityRevenueRecognized_12_Q3_USD":0.0,"ProceedsFromConvertibleDebt_3_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":2371291000.0,"OperatingLeaseCost_3_Q3_USD":13700000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":1974000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":14099000.0,"InventoryNet_0_Q3_USD":111873000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":20649000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":2742000.0,"OperatingIncomeLoss_1_Q3_USD":21939000.0,"OperatingIncomeLoss_3_Q3_USD":8358000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":6800000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":428064000.0,"CommonStockSharesAuthorized_0_Q3_shares":1000000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-13111000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":4788000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":8531000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"OperatingLeaseRightOfUseAsset_0_Q3_USD":36485000.0,"ShareBasedCompensation_3_Q3_USD":6777000.0,"GainLossOnSaleOfInvestments_3_Q3_USD":10324000.0,"Assets_0_Q3_USD":2371291000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":940739000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":1600000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":4880000.0,"OperatingExpenses_3_Q3_USD":932381000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1_Q3_USD":62000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_3_Q3_USD":156000.0,"AssetImpairmentCharges_1_Q3_USD":0.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":107255000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-49158000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1514131000.0,"VariableLeaseCost_3_Q3_USD":2300000.0,"LongTermInvestments_0_Q3_USD":14325000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":9080000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":1996000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":2951000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":2343000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":45031000.0,"ProfitLoss_1_Q3_USD":23717000.0,"ProfitLoss_3_Q3_USD":-1712000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":0.04,"EarningsPerShareBasicAndDiluted_3_Q3_USD":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":0.0,"OperatingExpenses_1_Q3_USD":406125000.0,"EquityMethodInvestmentQuotedMarketValue_0_Q3_USD":6200000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":2907000.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20201029"}]